304 related articles for article (PubMed ID: 20053895)
1. Trans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy.
Coady TH; Lorson CL
J Neurosci; 2010 Jan; 30(1):126-30. PubMed ID: 20053895
[TBL] [Abstract][Full Text] [Related]
2. Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy.
Shababi M; Glascock J; Lorson CL
Hum Gene Ther; 2011 Feb; 22(2):135-44. PubMed ID: 20804424
[TBL] [Abstract][Full Text] [Related]
3. Optimization of SMN trans-splicing through the analysis of SMN introns.
Shababi M; Lorson CL
J Mol Neurosci; 2012 Mar; 46(3):459-69. PubMed ID: 21826391
[TBL] [Abstract][Full Text] [Related]
4. Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing.
Coady TH; Shababi M; Tullis GE; Lorson CL
Mol Ther; 2007 Aug; 15(8):1471-8. PubMed ID: 17551501
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
Cobb MS; Rose FF; Rindt H; Glascock JJ; Shababi M; Miller MR; Osman EY; Yen PF; Garcia ML; Martin BR; Wetz MJ; Mazzasette C; Feng Z; Ko CP; Lorson CL
Hum Mol Genet; 2013 May; 22(9):1843-55. PubMed ID: 23390132
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy.
Williams JH; Schray RC; Patterson CA; Ayitey SO; Tallent MK; Lutz GJ
J Neurosci; 2009 Jun; 29(24):7633-8. PubMed ID: 19535574
[TBL] [Abstract][Full Text] [Related]
7. Genomic Variability in the Survival Motor Neuron Genes (
Butchbach MER
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360669
[TBL] [Abstract][Full Text] [Related]
8. Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy.
Baughan TD; Dickson A; Osman EY; Lorson CL
Hum Mol Genet; 2009 May; 18(9):1600-11. PubMed ID: 19228773
[TBL] [Abstract][Full Text] [Related]
9. Splicing of the Survival Motor Neuron genes and implications for treatment of SMA.
Bebee TW; Gladman JT; Chandler DS
Front Biosci (Landmark Ed); 2010 Jun; 15(3):1191-1204. PubMed ID: 20515750
[TBL] [Abstract][Full Text] [Related]
10. Development of a single vector system that enhances trans-splicing of SMN2 transcripts.
Coady TH; Baughan TD; Shababi M; Passini MA; Lorson CL
PLoS One; 2008; 3(10):e3468. PubMed ID: 18941511
[TBL] [Abstract][Full Text] [Related]
11. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.
Hua Y; Sahashi K; Rigo F; Hung G; Horev G; Bennett CF; Krainer AR
Nature; 2011 Oct; 478(7367):123-6. PubMed ID: 21979052
[TBL] [Abstract][Full Text] [Related]
12. Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy.
Glascock JJ; Shababi M; Wetz MJ; Krogman MM; Lorson CL
Biochem Biophys Res Commun; 2012 Jan; 417(1):376-81. PubMed ID: 22172949
[TBL] [Abstract][Full Text] [Related]
13. Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy.
Mitrpant C; Porensky P; Zhou H; Price L; Muntoni F; Fletcher S; Wilton SD; Burghes AH
PLoS One; 2013; 8(4):e62114. PubMed ID: 23630626
[TBL] [Abstract][Full Text] [Related]
14. A negatively acting bifunctional RNA increases survival motor neuron both in vitro and in vivo.
Dickson A; Osman E; Lorson CL
Hum Gene Ther; 2008 Nov; 19(11):1307-15. PubMed ID: 19848583
[TBL] [Abstract][Full Text] [Related]
15. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
[TBL] [Abstract][Full Text] [Related]
16. Therapeutics development for spinal muscular atrophy.
Sumner CJ
NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells.
Pagliarini V; Guerra M; Di Rosa V; Compagnucci C; Sette C
J Neurochem; 2020 Apr; 153(2):264-275. PubMed ID: 31811660
[TBL] [Abstract][Full Text] [Related]
18. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
[TBL] [Abstract][Full Text] [Related]
19. Bifunctional RNAs targeting the intronic splicing silencer N1 increase SMN levels and reduce disease severity in an animal model of spinal muscular atrophy.
Osman EY; Yen PF; Lorson CL
Mol Ther; 2012 Jan; 20(1):119-26. PubMed ID: 22031236
[TBL] [Abstract][Full Text] [Related]
20. Heat increases full-length SMN splicing: promise for splice-augmenting therapies for SMA.
Dominguez CE; Cunningham D; Venkataramany AS; Chandler DS
Hum Genet; 2022 Feb; 141(2):239-256. PubMed ID: 35088120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
